info@allievapharma.com

  • 24/7
    Customer Service
  • ISO 9001
    Certification Company
  • WHO-GMP
    Certified Company
OUR CATALOGUE OUR CATALOGUE

    • Kidney Cancer

    Kidney Cancer Products

    Discover a wide range of Kidney Cancer products under the Oncology category. Allieva Pharma provides high-quality pharmaceutical solutions trusted across India and global markets.

    SORALIEVA 200MG Sorafenib Tablets 200mg by SORALIEVA 200MG

    SORALIEVA 200MG

    Sorafenib Tablets 200mg

    SORALIEVA contains Sorafenib, an oral multi-kinase inhibitor. It blocks multiple kinases involved in tumor cell proliferation and angiogenesis, including RAF kinases, VEGFR, and PDGFR, slowing tumor growth.

    View Details
    AXILIEVA 5MG Axitinib Tablets 5 mg by AXILIEVA 5MG

    AXILIEVA 5MG

    Axitinib Tablets 5 mg

    AXILIEVA contains Axitinib, an oral targeted anticancer agent. It is a tyrosine kinase inhibitor (TKI) that selectively blocks vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3), inhibiting angiogenesis and tumor growth.

    View Details
    SUNITCAP 50MG Sunitinib Malate Capsules 50mg by SUNITCAP 50MG

    SUNITCAP 50MG

    Sunitinib Malate Capsules 50mg

    SUNITCAP 50 mg contains Sunitinib malate, an oral targeted anticancer medicine. It is a multi-targeted tyrosine kinase inhibitor (TKI) that blocks receptors involved in tumor growth, angiogenesis (blood vessel formation), and cancer cell survival, thereby slowing cancer progression.

    View Details
    SUNITCAP 25MG Sunitinib Malate Capsules 25mg by SUNITCAP 25MG

    SUNITCAP 25MG

    Sunitinib Malate Capsules 25mg

    SUNITCAP 25 mg contains Sunitinib malate, an oral targeted anticancer medicine. It is a multi-targeted tyrosine kinase inhibitor (TKI) that inhibits receptors involved in tumor growth, angiogenesis, and cancer cell survival, thereby slowing disease progression.

    View Details
    SUNITCAP 12.5MG Sunitinib Malate Capsules 12.5mg by SUNITCAP 12.5MG

    SUNITCAP 12.5MG

    Sunitinib Malate Capsules 12.5mg

    SUNITCAP 12.5 mg contains Sunitinib malate, an oral targeted anticancer medicine. It is a multi-targeted tyrosine kinase inhibitor (TKI) that blocks receptors involved in tumor growth, angiogenesis (blood vessel formation), and cancer cell survival, thereby slowing disease progression.

    View Details
    • 1

    24/7 Clients Support

    Best Price

    Quality Assurance